Precision Medicine in Breast Medicine: A Real Change for Thousands of Women
Gianluca Franceschini, Director of the Integrated Center for Senology and the Breast Surgery Unit of the Gemelli Polyclinic, posted on LinkedIn:
”Precision medicine in Breast Medicine: a real change for thousands of women.
As Director of the Integrated Breast Center of the Gemelli Polyclinic, I see every day how scientific innovation can concretely transform the treatment path of our patients.
- Genomic tests, such as Oncotype DX, are rewriting the therapeutic approach to hormone-responsive breast cancers, which account for more than 70% of diagnoses.
- These tools help us understand who really benefits from chemotherapy and who can be safely treated with hormone therapy alone.
The result?
Thousands of women can avoid unnecessarily heavy treatments without reducing the effectiveness of treatment.
It is a decisive step forward in terms of quality of life, sustainability and personalization of treatment.
We continue to work – together with colleagues in Precision Medicine and National Research Groups – to further expand their use, even in the pre-operative phase, and to define increasingly personalized therapeutic strategies.
Precision medicine is not the future: it is already here. And it’s changing the lives of our patients, one treatment decision at a time.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Alessandra Fabi
Gianluca Franceschini ”
Read more here.
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
-
Nov 29, 2025, 16:38PF4 Antibody Persistence and Long-term Pathogenicity in VITT
